The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
19 10k trades in the last hour totalling 360k, something very strange going on. Think they may all be buys just below the mid-price. That would certainly tally with the late rise into close. Let's see if we get the same trading pattern when we open.
I think they will approve and licence for an American outfit to produce it for the US Market, that way they can claim 'made in the USA'. Its a little like WW2, Britain does the hard work and then they swoop in and try to claim the win, but if it puts a couple of billion quid in the bank then they can tell their citizens whatever the heck they want.
Wonder if we have a leaky ship, and if so what whisper is it? Emergency approval from the FDA? forward orders from a world super power? JV agreement with a big pharma? Offer tabled for the business? The mind boggles, just know I wouldn't want to be out of this!
So the company manages to supply the world with a product to beat the most deadly pandemic for a century, it then also provides the world with a drug that helps with COPD whilst continually developing and trialing new products. Lots of talk of selling at 200, 240, 700, 1400. Personally I don't want a buyout as I want to be a holder of company that licenses all these products to a global market and live off the future divi's, and use the gains to fund my retirement!
What is the likleyhood of forward orders being placed prior to home test trial completion? The UK government have already placed massive orders for vaccines yet to be proven so they can be at the front of the queue. What are the chances over the coming days that the UK has done the same with this treatment and will there be a scramble from the world powerhouses to get their names on the order book?
Somebody has been buying in 5 mil tranches all day, even if the late reported was shown as a sell im certain it was another buy, be very interesting to see if we get a holdings notification early next week, still under the radar for most but definitely going to be a very entertaining week to come, happy weekend all holders.
Having read the un-audited results they are better than I was expecting, and a further reduction in cost from $13 to $11 per barrel is impressive. Assuming the additional perforation at HH1 increases production to 400bopd then gross profit for 12 months would be $3.6MM. That's just from one working well, and as we don't have Loxley to worry about the next project will be to add a couple of wells to HH.
"Revenue for the six months saw a reduction from £0.1 million to £0.08 million, which was a result of lower oil price and lower production from the non-operated Horndean oil field. Oil sales from the Horse Hill field were not included in the revenue line but rather netted of exploration and evaluation expenditure."